purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunológicos para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - imunológicos para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
senspert felv ag/ fiv ab teste kit
laboratÓrios vencofarma do brasil ltda. - antÍgenos, kits de detecÇÃo e testes; diluentes; - testes
topiramato alter 100 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 100 mg - topiramato 100 mg - topiramate - genérico - duração do tratamento: longa duração
topiramato alter 50 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 50 mg - topiramato 50 mg - topiramate - genérico - duração do tratamento: longa duração
topiramato alter 25 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 25 mg - topiramato 25 mg - topiramate - genérico - duração do tratamento: longa duração
topiramato alter 50 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 50 mg - topiramato 50 mg - topiramate - genérico - duração do tratamento: longa duração
topiramato alter 25 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 25 mg - topiramato 25 mg - topiramate - genérico - duração do tratamento: longa duração
topiramato alter 25 mg comprimido revestido por película
alter, s.a. - topiramato - comprimido revestido por película - 25 mg - topiramato 25 mg - topiramate - genérico - duração do tratamento: longa duração
dimidon 400 mg comprimido revestido por película
laboratórios basi - indústria farmacêutica, s.a - ibuprofeno - comprimido revestido por película - 400 mg - ibuprofeno 400 mg - ibuprofen - n/a - duração do tratamento: curta ou média duração